Dr. Erich G. Anderer

And there are just many other factors that go into that that may seem sort of boring or whatever, but that you have to take into account.

So honestly, I would say it's mostly sort of the regulatory financial environment that is probably what's giving the most headwinds to this type of growth that we're speaking of.

You know, I mean, I think that disruptor is interesting.

So, I mean, clearly the obvious answer to that and if any surgical field is going to be tech, right?

So, you know, advanced robotics and this kind of thing, I think.

But I, um, you know, I would say if we're talking disruption and just sort of thinking outside the box here, it's just, there's just so much stuff going on, um, with AI predictive, predictive analytics, like all this, um, you know, where, where I think that we're actually going to probably end up, um, you know, basing, uh, some treatment on algorithms that were sort of written, um, via some kind of AI model.

Um, and a lot of that's actually being done in the

At NYU, it certainly is, you know, where we can sort of use de-identified data to like, you know, if somebody comes in with this complaint at this time of day with this, you know, we can almost predict kind of where they're going to go, what kind of

problem they're going to have, where they're going to get discharged to, all these things, which I think is going to be sort of interesting because clearly it's, you know, we're going to have to have some sort of human oversight into how this is done.

But, you know, to sort of harness the power of AI and tech in general, I think for these types of things is really going to change the way that we diagnose and treat disease.